The primary and the recurrent tumors share the same G12D KRAS mutation (very common in pancreatic ductal adenocarcinoma), but their different morphology suggests discordant mutations in genes that were not considered in our panel of 11 genes. This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.